These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15852896

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Value of blood adipose tissue hormones concentration--adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction.
    Piestrzeniewicz K, Luczak K, Goch JH.
    Neuro Endocrinol Lett; 2008 Aug; 29(4):581-8. PubMed ID: 18766137
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC, Lima JC, Rocha MS, D'Oliveira Junior A, Péricles Esteves J.
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [Abstract] [Full Text] [Related]

  • 25. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
    Leone AM, Rutella S, Giannico MB, Perfetti M, Zaccone V, Brugaletta S, Garramone B, Niccoli G, Porto I, Liuzzo G, Biasucci LM, Bellesi S, Galiuto L, Leone G, Rebuzzi AG, Crea F.
    Int J Cardiol; 2008 Nov 28; 130(3):457-62. PubMed ID: 18667247
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S, Manhenke C, Squire IB, Ng L, Anand I, Dickstein K.
    J Card Fail; 2007 Dec 28; 13(10):843-9. PubMed ID: 18068618
    [Abstract] [Full Text] [Related]

  • 31. Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction.
    Sanchis J, Bodí V, Llácer A, Núñez J, Facila L, Ruiz V, Blasco M, Sanjuán R, Chorro FJ.
    Am J Cardiol; 2004 Sep 15; 94(6):766-9. PubMed ID: 15374783
    [Abstract] [Full Text] [Related]

  • 32. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.
    J Cardiovasc Med (Hagerstown); 2007 Apr 15; 8(4):293-9. PubMed ID: 17413310
    [Abstract] [Full Text] [Related]

  • 33. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG, Xu F, Zhang Y, Ji QS, Sun Y, Lü RJ, Li RJ.
    Chin Med J (Engl); 2006 Jan 05; 119(1):32-6. PubMed ID: 16454979
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hemodynamic effects of warm bathing in a Hubbard tank and exercise loading in patients after myocardial infarction.
    Kawamura K, Ozawa M, Sorimachi M, Ueda H, Ebato S, Ando H, Hasegawa M, Matsuzaki A, Katagiri T.
    J Cardiol; 1997 Nov 05; 30(5):231-9. PubMed ID: 9395954
    [Abstract] [Full Text] [Related]

  • 36. Incidence and clinical impact of right bundle branch block in patients with acute myocardial infarction: ST elevation myocardial infarction versus non-ST elevation myocardial infarction.
    Kleemann T, Juenger C, Gitt AK, Schiele R, Schneider S, Senges J, Darius H, Seidl K, MITRA PLUS Study Group.
    Am Heart J; 2008 Aug 05; 156(2):256-61. PubMed ID: 18657654
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
    Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, McCabe CH, Skene AM, Gibson CM, Ridker PM, Braunwald E, PROVE IT-TIMI 22 Investigators.
    J Am Coll Cardiol; 2005 Oct 18; 46(8):1417-24. PubMed ID: 16226164
    [Abstract] [Full Text] [Related]

  • 39. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M, Stasik-Pres G, Pres D, Lech P, Gierlotka M, Lekston A, Hawranek M, Tajstra M, Kalarus Z, Poloński L.
    Kardiol Pol; 2007 Sep 18; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [Abstract] [Full Text] [Related]

  • 40. ["Smoker's paradox" in patients with acute myocardial infarction receiving primary coronary intervention].
    Katayama T, Iwasaki Y, Yamamoto T, Yoshioka M, Nakashima H, Suzuki S, Honda Y, Yano K.
    J Cardiol; 2006 Oct 18; 48(4):193-200. PubMed ID: 17066622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.